Insider · CIK 0002013869
Jonathan Goldman
Files at AVTX (Avalo Therapeutics, Inc.). First filing Nov 17, 2025, latest Nov 17, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AVTX: Avalo Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | AVTXsell Avalo Therapeutics, Inc. | $163k 11,367 shares | -359% | +321% from low-18% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | AVTX Avalo Therapeutics, Inc. | SOpen-market sale Common Stock | -3,167 | $14.30 | $45k | 0 | Nov 17, 2025 |
| Nov 14, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Common Stock | +8,200 | $9.88 | $81k | 8,200 | Nov 17, 2025 |
| Nov 14, 2025 | AVTX Avalo Therapeutics, Inc. | SOpen-market sale Common Stock | -8,200 | $14.35 | $118k | 0 | Nov 17, 2025 |
| Nov 14, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -8,200 | $0.00 | $0 | 16,400 | Nov 17, 2025 |
| Jun 17, 2025 | AVTX Avalo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,100 | $0.00 | $0 | 20,100 | Jun 18, 2025 |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Common Stock | +3,167 | - | - | 3,167 | Apr 1, 2025 |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,167 | $0.00 | $0 | 6,333 | Apr 1, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.